CytoDyn Inc.
1111 Main Street, Suite 660
Vancouver, Washington 98660
May 6, 2020
VIA EDGAR SUBMISSION
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Re: REQUEST FOR ACCELERATION OF EFFECTIVENESS
CytoDyn Inc.
Registration Statement on Form S-3
File No. 333-236198
Ladies and Gentlemen:
CytoDyn Inc. (the “Company”) hereby respectfully requests the acceleration of the effectiveness of the above-referenced Registration Statement (the “Registration Statement”) so that the Registration Statement will become effective at 4:30 p.m. (Eastern time) on Monday, May 11, 2020, or as soon thereafter as practicable.
The Company requests the Commission confirm the effective date and time of the Registration Statement to Kara Tatman of Perkins Coie LLP, counsel to the Company, by telephone at (503) 727-2171.
Very truly yours, |
CytoDyn Inc. |
/s/ Michael D. Mulholland |
Michael D. Mulholland |
Interim Chief Financial Officer |
cc: Kara Tatman (Perkins Coie LLP)